Bangkok Dusit Medical Services (BDMS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Auditor issued an unqualified opinion, confirming fair presentation of financial statements as of 31 December 2024 in accordance with Thai Financial Reporting Standards.
Key audit matters included revenue recognition (95% of total revenues) and goodwill impairment, both requiring significant management judgment.
Financial highlights
Total revenues reached THB 109.4 billion for 2024, with hospital operations contributing THB 103.7 billion.
Net profit attributable to owners was THB 15.99 billion, up from THB 14.36 billion in 2023.
Basic EPS was THB 1.01, compared to THB 0.90 in the prior year.
Total assets increased to THB 151.5 billion from THB 143.8 billion year-over-year.
Total equity attributable to owners rose to THB 100.0 billion from THB 95.4 billion.
Segment performance
Hospital operations accounted for 95% of consolidated revenues, with the remainder from sales of goods and other income.
Latest events from Bangkok Dusit Medical Services
- 2025 revenue rose to THB 113,272 million, with net profit at THB 15,848 million and higher dividends.BDMS
Q4 20252 Mar 2026 - Net profit rose to ฿12.16 billion on higher revenue, international growth, and network expansion.BDMS
Q3 202513 Nov 2025 - Revenue and profit rose 4–6% YoY, driven by international patients and network expansion.BDMS
Q2 202515 Aug 2025 - 9M24 net profit rose 12% to ฿11.65 billion on revenue of ฿81.6 billion, driven by patient growth.BDMS
Q3 202413 Jun 2025 - Net profit rose 14% in H1 2024, driven by hospital growth and international patient revenue.BDMS
Q2 202413 Jun 2025 - Net profit rose over 6% YoY, supported by international and upcountry hospital growth.BDMS
Q1 20256 Jun 2025